Scientific Presentations CTAD 2022 (November 29-December 2) December 1, 2022 – CTAD 2022 (Moebius et al) Fosgonimeton Provides Congruent Benefit on Diverse Biomarkers of Neurodegeneration, Significantly Correlating With a Composite Clinical Score of Cognition and Function in Alzheimer’s Disease Watch Video Presentation
